Patrick (Paddy) Mallon
机构: Centre for Experimental Pathogen Host Research, University College Dublin
每年引用次数
引用次数
引用: 7,833
H-指数: 49
I10-指数 : 139
出版物: 399
Adverse effects of current ARVs: myths and realities
P Mallon
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 21
2018
Platelet function upon switching to tenofovir alafenamide (TAF) verses continuing abacavir (ABC): a randomised substudy OVERRIDE
P Mallon , A Winston , F Post , C Bergin
HIV MEDICINE 19 S17 -S18
2018
USE OF LIPID LOWERING THERAPY (LLT) AND ACHEVEMENT OF RECOMMENDED TARGETS IN AN AGING COHORTOF PEOPLE LIVING WITH HIV
HK Gill , C Boyle , W Tinago , A Macken
IRISH JOURNAL OF MEDICAL SCIENCE 186 S465 -S465
2017
Analysis of an HIV cohort cascade in the context of the UNAIDS 90: 90: 90 strategy
B Ghavami-Kia , P McGettrick , A Macken , W Tinago
HIV MEDICINE 16 51 -51
2015
Pre-exposure prophylaxis (PrEP) option for HIV-negative gay men and transgender women in Ireland: Online feasibility survey
A Macken , J O'Halloran , P Mallon , G O'Connor
HIV MEDICINE 16 25 -25
2015
THE EFFECTS OF HIV PROTEASE INHIBITORS ON INSULIN SIGNALLING IN HEPATOCYTES
S Lee , R Maughan , P Mallon
IRISH JOURNAL OF MEDICAL SCIENCE 182 S491 -S491
2013
ACUTE INFECTIONS IN CURRENT AND PAST INJECTING DRUG USERS PRESENTING TO AN INNER-CITY EMERGENCY DEPARTMENT
S Connolly , G O'Connor , P Mallon
IRISH JOURNAL OF MEDICAL SCIENCE 182 S491 -S492
2013
Effect of nucleoside reverse transcriptase inhibitors (NRTIs) on CD4 recovery for individuals on long-term, fully suppressive antiretroviral therapy (ART)
H Byakwaga , J Zhou , M Law , S Emery
ANTIVIRAL THERAPY 12 ( 6) L61 -L62
2007
Minor changes in calculated creatinine clearance and anion‐gap are associated with tenofovir disoproxil fumarate‐containing highly active antiretroviral therapy
A Winston , J Amin , PWG Mallon , D Marriott
Hiv Medicine 7 ( 2) 105 -111
85
2006
Early changes in adipokine levels and baseline limb fat may predict HIV lipoatrophy over 2 years following initiation of antiretroviral therapy.
A Calmy , D Carey , PWG Mallon , H Wand
Hiv Medicine 9 ( 2) 101 -110
9
2008
Hyperlactataemia in HIV‐infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial)
ER Feeney , C Chazallon , N O'Brien , V Meiffrédy
Hiv Medicine 12 ( 10) 602 -609
5
2011
HIV-associated lipodystrophy.
PWG Mallon , DA Cooper , A Carr
Hiv Medicine 2 ( 3) 166 -173
53
2001
Characterization of associations and development of atazanavir resistance after unplanned treatment interruptions.
W Tinago , JA O'Halloran , RM O'Halloran , A Macken
Hiv Medicine 15 ( 4) 224 -232
6
2014
The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV‐1 infection
JA O'Halloran , E Dunne , MMP Gurwith , JS Lambert
Hiv Medicine 16 ( 10) 608 -619
38
2015
Depression, lifestyle factors and cognitive function in people living with HIV and comparable HIV-negative controls.
D De Francesco , J Underwood , E Bagkeris , M Boffito
Hiv Medicine 20 ( 4) 274 -285
11
2019
High-risk behaviours, and their associations with mental health, adherence to antiretroviral therapy and HIV parameters, in HIV-positive men who have sex with men.
ERM Pool , A Winston , E Bagkeris , JH Vera
Hiv Medicine 20 ( 2) 131 -136
4
2019
The rate of bone loss slows after 1-2 years of initial antiretroviral therapy: final results of the Strategic Timing of Antiretroviral Therapy (START) bone mineral density substudy.
A Carr , B Grund , AV Schwartz , A Avihingsanon
Hiv Medicine 21 ( 1) 64 -70
2
2020
Response to: 'How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?'
A Winston , A Cotter , M Gisslen , PWG Mallon
Hiv Medicine 21 ( 7)
2020
Factors associated with obesity in the Pharmacokinetic and Clinical Observations in People over Fifty (POPPY) cohort: an observational cross-sectional analysis
S Savinelli , D De Francesco , ER Feeney , D Babalis
Hiv Medicine 21 ( 7) 441 -452
2
2020
Respiratory symptoms and chronic bronchitis in people with and without HIV infection.
CA Sabin , KM Kunisaki , E Bagkeris , FA Post
Hiv Medicine 22 ( 1) 11 -21
2
2021